Synovitis in systemic sclerosis is an interferon-driven stromal condition distinct from rheumatoid arthritis
Celina GeißiD, Camino Calvo-CebriániD, Miranda HoutmaniD, Ege EzeniD, Katerina ApostolopoulouiD, Cristian IperiiD, Melpomeni ToitouiD, Alexandra A. KhmelevskayaiD, Marija LugariD, Anne CauvetiD, Yannis DjeffaliD, Mojca Frank‐BertonceljiD, Sam G. Edalat, Thomas RaueriD, Katharina Zachariassen, Kristina BuerkiiD, Cosimo BruniiD, Chantal PauliiD, Michael Markus BonelliiD, Thomas KaronitschiD, Yannick AllanoreiD, Raphael MicheroliiD, Oliver DistleriD, Caroline OspeltiD, Muriel ElhaïiD
Abstract
Joint involvement is a major driver of disability in systemic sclerosis (SSc), yet its pathophysiology remains poorly understood. In the absence of specific evidence, SSc synovitis is treated by analogy with rheumatoid arthritis (RA). Here, we present the first comprehensive molecular characterization of SSc synovitis, integrating histology, single-cell RNA sequencing, and spatial multi-omics of synovial biopsies from SSc patients, RA patients, and non-inflammatory controls with in vitro validation. We show that SSc synovitis is characterized by distinct pathomechanisms from RA. Histologically, most SSc biopsies displayed a pauci-immune pathotype with sparse immune infiltrates and predominant stromal cells. At molecular level, synovial fibroblasts in SSc were characterized by a disease-specific type I interferon (IFN) response program, in contrast to the TNF-dominant profile of RA, accompanied by dysregulation of the complement cascade. This IFN program extended across multiple synovial cell types, including monocyte-derived macrophages and endothelial cells, and was spatially organized into focal myeloid niches and a diffuse stromal program. Systemically, elevated serum IFN-2a levels were associated with the presence of clinical synovitis in an independent cohort of SSc patients. We furthermore show that similar IFN-driven programs are shared between skin and synovium in SSc. Genes downregulated by IFNAR1 blockade in SSc skin were enriched in SSc synovium, supporting IFN receptor blockade as a multi-organ target therapeutic strategy. These findings reframe SSc synovitis as a less destructive, IFN-driven stromal condition distinct from RA and provide a mechanistic basis for dedicated clinical trials for joint inflammation in SSc. One Sentence SummarySSc synovitis is a pauci-immune, IFN-driven stromal condition distinct from RA, supporting IFNAR1 blockade as a therapeutic strategy. Graphical abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=110 SRC="FIGDIR/small/733140v1_ufig1.gif" ALT="Figure 1"> View larger version (41K): org.highwire.dtl.DTLVardef@d85bb5org.highwire.dtl.DTLVardef@6cffe6org.highwire.dtl.DTLVardef@148eb4org.highwire.dtl.DTLVardef@1a4cd83_HPS_FORMAT_FIGEXP M_FIG C_FIG
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Synovial fibroblast niche shapes the efficacy - safety dynamics of JAK inhibition in rheumatoid arthritis
Ana Županič, Sam G. Edalat, … Mojca Frank‐Bertoncelj·bioRxiv·Mar 25, 2026
- Discrete cytokine signaling networks instruct distinctsynovial pathotypes in inflammatory arthritis
Alicia Derrac Soria, David Gregory Hill, … Simon A. Jones·bioRxiv·Nov 1, 2025
- Disease-specific fibroblast-myeloid interactions in rheumatoid arthritis synovium
Alexandra A. Khmelevskaya, Katerina Apostolopoulou, … Caroline Ospelt·bioRxiv·Nov 17, 2025
- Chloride intracellular channel 4 (CLIC4) is a global regulator of type 1 interferon signaling in Systemic Sclerosis (SSc) epithelial cells
Christopher W. Wasson, Sophie L. Dibb, … Francesco Del Galdo·bioRxiv·Mar 8, 2024
- Peripheral T Helper Cells Dominate the Synovial CD4⁺ T Cell Compartment in Systemic Juvenile Idiopathic Arthritis and Are Shaped by IL-1β and IL-18
Johannes Dirks, Jonas Fischer, … Henner Morbach·bioRxiv·Jul 3, 2025
- Heterogeneity of Inflammation-associated Synovial Fibroblasts in Rheumatoid Arthritis and Its Drivers
M. H. Smith, V. R. Gao, … A. Y. Rudensky·bioRxiv·Feb 28, 2022